Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 13Dermatologic 2CNS 2Breast 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1Endocrine 1

Conditions

Glioblastoma 14Brain Neoplasms 11Gliosarcoma 8Glioma 7Oligodendroglioma 5Central Nervous System Neoplasms 5Astrocytoma 5Neoplasm Metastasis 4Neuroblastoma 3Breast Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Pinealoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Pheochromocytoma 1Pharyngeal Neoplasms 1Paraganglioma, Extra-Adrenal 1Pancreatic Neoplasms 1Osteosarcoma 1Neurofibromatosis 2 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Neoplasms, Mesothelial 1

Interventions

Radiotherapy 5Magnetic Resonance Spectroscopy 5Docetaxel 5Specimen Handling 4Gemcitabine 3Cyclophosphamide 3temsirolimus 2fludarabine 2Trastuzumab 2Temozolomide 2Sirolimus 2Radiosurgery 2Paclitaxel 2Oxaliplatin 2Nivolumab 2Leucovorin 2Injections 2Fluorouracil 2Fluorodeoxyglucose F18 2Blood Specimen Collection 2Biopsy 2Bevacizumab 2Azacitidine 2vandetanib 1ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Neoplasms × temsirolimus × CNS × Clear all
NCT01155258 2016-06-13

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

University of Southern California

Phase 1 Completed
19 enrolled
BreastCNSDermatologicEndocrineGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Paraganglioma, Extra-Adrenal, Pheochromocytoma, Prostatic Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary, Breast Neoplasms, Male, Small Cell Lung Carcinoma

NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

M.D. Anderson Cancer Center

Phase 1 Completed
180 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡